Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments.

Barry KC, Hsu J, Broz ML, Cueto FJ, Binnewies M, Combes AJ, Nelson AE, Loo K, Kumar R, Rosenblum MD, Alvarado MD, Wolf DM, Bogunovic D, Bhardwaj N, Daud AI, Ha PK, Ryan WR, Pollack JL, Samad B, Asthana S, Chan V, Krummel MF.

Nat Med. 2018 Jun 25. doi: 10.1038/s41591-018-0085-8. [Epub ahead of print]

PMID:
29942093
2.

Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.

Sánchez-Paulete AR, Teijeira A, Cueto FJ, Garasa S, Pérez-Gracia JL, Sánchez-Arráez A, Sancho D, Melero I.

Ann Oncol. 2017 Dec 1;28(suppl_12):xii74. doi: 10.1093/annonc/mdx727. No abstract available.

PMID:
29253116
3.

Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.

Sánchez-Paulete AR, Teijeira A, Cueto FJ, Garasa S, Pérez-Gracia JL, Sánchez-Arráez A, Sancho D, Melero I.

Ann Oncol. 2017 Dec 1;28(suppl_12):xii44-xii55. doi: 10.1093/annonc/mdx237. Erratum in: Ann Oncol. 2017 Dec 1;28(suppl_12):xii74.

PMID:
28945841
4.

Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells.

Enamorado M, Iborra S, Priego E, Cueto FJ, Quintana JA, Martínez-Cano S, Mejías-Pérez E, Esteban M, Melero I, Hidalgo A, Sancho D.

Nat Commun. 2017 Jul 17;8:16073. doi: 10.1038/ncomms16073.

5.

Rational design of adjuvants targeting the C-type lectin Mincle.

Decout A, Silva-Gomes S, Drocourt D, Barbe S, André I, Cueto FJ, Lioux T, Sancho D, Pérouzel E, Vercellone A, Prandi J, Gilleron M, Tiraby G, Nigou J.

Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):2675-2680. doi: 10.1073/pnas.1612421114. Epub 2017 Feb 21.

6.

Leishmania Uses Mincle to Target an Inhibitory ITAM Signaling Pathway in Dendritic Cells that Dampens Adaptive Immunity to Infection.

Iborra S, Martínez-López M, Cueto FJ, Conde-Garrosa R, Del Fresno C, Izquierdo HM, Abram CL, Mori D, Campos-Martín Y, Reguera RM, Kemp B, Yamasaki S, Robinson MJ, Soto M, Lowell CA, Sancho D.

Immunity. 2016 Oct 18;45(4):788-801. doi: 10.1016/j.immuni.2016.09.012. Epub 2016 Oct 11.

7.

Optimal Generation of Tissue-Resident but Not Circulating Memory T Cells during Viral Infection Requires Crosspriming by DNGR-1+ Dendritic Cells.

Iborra S, Martínez-López M, Khouili SC, Enamorado M, Cueto FJ, Conde-Garrosa R, Del Fresno C, Sancho D.

Immunity. 2016 Oct 18;45(4):847-860. doi: 10.1016/j.immuni.2016.08.019. Epub 2016 Sep 27.

8.

Pleiotropic effects of antitumour alkylphospholipids on cholesterol transport and metabolism.

Ríos-Marco P, Marco C, Cueto FJ, Carrasco MP, Jiménez-López JM.

Exp Cell Res. 2016 Jan 1;340(1):81-90. doi: 10.1016/j.yexcr.2015.12.012. Epub 2015 Dec 19.

PMID:
26712518
9.

Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells.

Sánchez-Paulete AR, Cueto FJ, Martínez-López M, Labiano S, Morales-Kastresana A, Rodríguez-Ruiz ME, Jure-Kunkel M, Azpilikueta A, Aznar MA, Quetglas JI, Sancho D, Melero I.

Cancer Discov. 2016 Jan;6(1):71-9. doi: 10.1158/2159-8290.CD-15-0510. Epub 2015 Oct 22.

10.

Anti-HCV RNA Aptamers Targeting the Genomic cis-Acting Replication Element.

Marton S, Berzal-Herranz B, Garmendia E, Cueto FJ, Berzal-Herranz A.

Pharmaceuticals (Basel). 2011 Dec 28;5(1):49-60. doi: 10.3390/ph5010049.

Supplemental Content

Loading ...
Support Center